Scott L. Burrows - Sep 16, 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Chief Financial Officer
Signature: /s/ Scott L. Burrows
Stock symbol: ARQT
Transactions as of: Sep 16, 2022
Transactions value $: $8,403
Form type: 4
Date filed: 9/20/2022, 04:37 PM
Previous filing: Mar 7, 2022
Next filing: Mar 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Options Exercise	$8.4K	+5K	+14.18%	$1.68^*	40.3K	Sep 16, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARQT	Stock Option (Right to Buy)	Options Exercise	$0	-5K	-11.83%	$0.00	37.3K	Sep 16, 2022	Common Stock	5K	$1.68	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 17,400 restricted stock units.
F2	25% of the shares subject to the option vest on the one year anniversary measured from May 22, 2019 (the "Vesting Commencement Date") and 1/48th of the shares vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.

Content

Includes 17,400 restricted stock units.

25% of the shares subject to the option vest on the one year anniversary measured from May 22, 2019 (the "Vesting Commencement Date") and 1/48th of the shares vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.